Literature DB >> 21362034

Essential fatty acid status in teenage girls with eating disorders and weight loss.

I Swenne1, A Rosling, S Tengblad, B Vessby.   

Abstract

AIM: To explore the relationship between essential fatty acids (FA) and weight changes in adolescent girls with eating disorders (ED).
METHODS: Blood samples were obtained from 220 girls with ED and 39 healthy controls. The girls with ED were 15.3 ± 1.5 years of age and weighed 49.8 ± 8.7 kg (BMI 18.3 ± 2.8 kg/m(2)) after a weight loss of 6.8 ± 6.4 kg. FA were analysed in plasma phospholipids (PPL) and erythrocyte membranes (ERY).
RESULTS: The proportions of saturated and monounsaturated FA were increased during weight loss, while linoleic acid (18:2ω6) was decreased. The proportions of eicosapentanoic acid (EPA) (20:5ω3) and docosahexanoic acid (DHA) (22:6ω3) in PPL and ERY did not differ from controls. The activity of stearoyl-CoA-desaturase was increased as evidenced by an increased product/precursor ratio and correlated with the rate of weight loss. The activities of delta-6-desaturase and delta-5-desaturase did not differ from controls. The rate of weight loss was inversely correlated with delta-6-desaturase and directly correlated with delta-5-desaturase.
CONCLUSION: The FA profile indicates low-fat intake, fat mobilization from stores and an increased conversion of essential FA at the delta-5-desaturase step during weight loss in adolescent girls with ED. Normal levels of EPA and DHA were maintained.
© 2011 The Author(s)/Acta Paediatrica © 2011 Foundation Acta Paediatrica.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21362034     DOI: 10.1111/j.1651-2227.2011.02153.x

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  7 in total

Review 1.  The potential relevance of docosahexaenoic acid and eicosapentaenoic acid to the etiopathogenesis of childhood neuropsychiatric disorders.

Authors:  Alessandra Tesei; Alessandro Crippa; Silvia Busti Ceccarelli; Maddalena Mauri; Massimo Molteni; Carlo Agostoni; Maria Nobile
Journal:  Eur Child Adolesc Psychiatry       Date:  2016-12-17       Impact factor: 4.785

Review 2.  Personalized polyunsaturated fatty acids as a potential adjunctive treatment for anorexia nervosa.

Authors:  P Betty Shih; Christophe Morisseau; Thu Le; Blake Woodside; J Bruce German
Journal:  Prostaglandins Other Lipid Mediat       Date:  2017-09-02       Impact factor: 3.072

3.  Very long chain fatty acids are an important marker of nutritional status in patients with anorexia nervosa: a case control study.

Authors:  Miki Shimizu; Keisuke Kawai; Makoto Yamashita; Masayasu Shoji; Shu Takakura; Tomokazu Hata; Megumi Nakashima; Keita Tatsushima; Kazunari Tanaka; Nobuyuki Sudo
Journal:  Biopsychosoc Med       Date:  2020-07-17

4.  Essential Fatty Acid Plasma Profiles Following Gastric Bypass and Adjusted Gastric Banding Bariatric Surgeries.

Authors:  Rebekah Forbes; Danijela Gasevic; Emily M Watson; Thomas R Ziegler; Edward Lin; John R Burgess; Nana Gletsu-Miller
Journal:  Obes Surg       Date:  2016-06       Impact factor: 4.129

5.  Dysregulation of soluble epoxide hydrolase and lipidomic profiles in anorexia nervosa.

Authors:  P B Shih; J Yang; C Morisseau; J B German; A A Scott-Van Zeeland; A M Armando; O Quehenberger; A W Bergen; P Magistretti; W Berrettini; K A Halmi; N Schork; B D Hammock; W Kaye
Journal:  Mol Psychiatry       Date:  2015-03-31       Impact factor: 15.992

6.  Mediation analysis of erythrocyte lipophilic index on the association between BMI and risk of oral cancer.

Authors:  Yi Fan; Qing Chen; Yaping Wang; Jing Wang; Yanni Li; Sijie Wang; Yanfeng Weng; Qiujiao Yang; Chen Chen; Lisong Lin; Yu Qiu; Fa Chen; Jing Wang; Baochang He; Fengqiong Liu
Journal:  Lipids Health Dis       Date:  2022-10-08       Impact factor: 4.315

7.  Food-Intake Normalization of Dysregulated Fatty Acids in Women with Anorexia Nervosa.

Authors:  Nhien Nguyen; Michelle Dow; Blake Woodside; J Bruce German; Oswald Quehenberger; Pei-An Betty Shih
Journal:  Nutrients       Date:  2019-09-13       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.